ClinicalTrials.Veeva

Menu

The Experiences of Patients Living With Malignant Pleural Effusions

G

Gloucestershire Hospitals NHS Foundation Trust

Status

Unknown

Conditions

Malignant Pleural Effusion

Study type

Observational

Funder types

Other

Identifiers

NCT03235999
16/009/GHT

Details and patient eligibility

About

Up to 20 patients with malignant pleural effusions will be interviewed about their experiences of having this condition and its management.

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Adults diagnosed with a malignant pleural effusion
  2. Has undergone either talc pleurodesis or IPC
  3. Have signed a consent form prior to entering the study
  4. Life expectancy > 6 weeks based on LENT guidelines (Low/Moderate risk group) - The LENT score calculation assigns 0 (<1500 IU/L) or 1 (>1500 IU/L) for pleural fluid LDH level; 0 to 3 points for matching ECOG performance scores (3 and 4 are combined); 0 (<9) or 1 (>9) for neutrophil-to-lymphocyte ratio; and 0 (lowest risk), 1 (moderate risk), or 3 (highest risk) for tumor type.

Exclusion criteria

  1. Any patient who is unable to understand sufficient English to take part in the semi-structured interviews
  2. Weakness or fatigue sufficient so that the patient is unable to take part in the interviews

Trial design

20 participants in 2 patient groups

Talc pleurodesis
Description:
Up to 10 patients who have had talc pleurodesis
IPC
Description:
Up to 10 patients who have had indwelling pleural catheters (IPC)

Trial contacts and locations

1

Loading...

Central trial contact

Mark Walker

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems